Comparative toxicological studies of amphotericin B methyl ester and amphotericin B in mice, rats, and dogs. 1976

G R Keim, and P L Sibley, and Y H Yoon, and J S Kulesza, and I H Zaidi, and M M Miller, and J W Poutsiaka

In acute and subacute toxicological studies, amphotericin B methyl ester was shown to be much less toxic than the parent antibiotic. As a single intravenous dose in mice, the methyl ester was approximately 20 times less toxic than amphotericin B. Also, the acute toxicity of the methyl ester in mice was not enhanced by the presence of chemically induced hepatic or renal damage or by the concurrent administration of amphotericin B or flucytosine. In a 1-month intraperitoneal study in rats, the methyl ester was about one-fourth as nephrotoxic as amphotericin B. In a 1-month intravenous study in dogs, the methyl ester was about one-eighth as nephrotoxic and one-fourth to one-half as hepatotoxic as the parent compound. In addition, the methyl ester, unlike amphotericin B, produced minimal renal effects, which did not increase in severity with increasing dosage. Based on the results of these studies, it is concluded that amphotericin B methyl ester has the potential for an improved therapeutic ratio in the treatment of systemic mycoses.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

G R Keim, and P L Sibley, and Y H Yoon, and J S Kulesza, and I H Zaidi, and M M Miller, and J W Poutsiaka
August 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology,
G R Keim, and P L Sibley, and Y H Yoon, and J S Kulesza, and I H Zaidi, and M M Miller, and J W Poutsiaka
November 1981, Antimicrobial agents and chemotherapy,
G R Keim, and P L Sibley, and Y H Yoon, and J S Kulesza, and I H Zaidi, and M M Miller, and J W Poutsiaka
January 1988, Toxicologic pathology,
G R Keim, and P L Sibley, and Y H Yoon, and J S Kulesza, and I H Zaidi, and M M Miller, and J W Poutsiaka
February 1975, The Journal of antibiotics,
G R Keim, and P L Sibley, and Y H Yoon, and J S Kulesza, and I H Zaidi, and M M Miller, and J W Poutsiaka
November 1987, Antimicrobial agents and chemotherapy,
G R Keim, and P L Sibley, and Y H Yoon, and J S Kulesza, and I H Zaidi, and M M Miller, and J W Poutsiaka
February 1973, Science (New York, N.Y.),
G R Keim, and P L Sibley, and Y H Yoon, and J S Kulesza, and I H Zaidi, and M M Miller, and J W Poutsiaka
January 1975, Antimicrobial agents and chemotherapy,
G R Keim, and P L Sibley, and Y H Yoon, and J S Kulesza, and I H Zaidi, and M M Miller, and J W Poutsiaka
March 1993, Antimicrobial agents and chemotherapy,
G R Keim, and P L Sibley, and Y H Yoon, and J S Kulesza, and I H Zaidi, and M M Miller, and J W Poutsiaka
October 1977, Antimicrobial agents and chemotherapy,
G R Keim, and P L Sibley, and Y H Yoon, and J S Kulesza, and I H Zaidi, and M M Miller, and J W Poutsiaka
January 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene,
Copied contents to your clipboard!